Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1395
TNBC
Basal B
GSK461364
PLK1
PLK
9254.001
uM
0.00450
0.00522
-1.0000 -0.5435 5.0000 1.0717
0.8911
0.3986
HCC1395
TNBC
Basal B
GSK461364
PLK1
PLK
7816.001
uM
0.00151
0.00173
-0.9805 -0.4672 4.9998 1.1061
0.9094
1.0243
HCC1395
TNBC
Basal B
GSK461364
PLK1
PLK
7813.001
uM
0.01050
0.01379
-0.9995 -0.5491 2.7174 0.8875
0.9467
0.7338
HCC1395
TNBC
Basal B
GSK461364
PLK1
PLK
9258.001
uM
0.00597
0.01523
-1.0000 -0.7752 1.0006 1.0407
0.9835
0.7137
HCC1395
TNBC
Basal B
GSK923295
CENPE
Kinesin
7813.001
uM
0.03847
0.05595
-0.7366 -0.5681 2.0268 0.8249
0.8970
0.7338
HCC1395
TNBC
Basal B
GSK923295
CENPE
Kinesin
7816.001
uM
0.03858
0.04680
-0.8697 -0.4666 3.4143 0.7175
0.9506
1.0243
HCC1395
TNBC
Basal B
GSK923295
CENPE
Kinesin
9258.001
uM
0.02841
0.04065
-0.7209 -0.6324 2.2816 0.8705
0.9726
0.7137
HCC1395
TNBC
Basal B
GSK923295
CENPE
Kinesin
9254.001
uM
0.02742
0.03281
-0.9898 -0.7258 5.0000 0.9333
0.9796
0.3986
HCC1395
TNBC
Basal B
GW-5074
CRAF
MAPK
7436.088
uM
inf
inf
0.7759 0.7759 0.0000 0.0514
0.5263
1.1615
HCC1395
TNBC
Basal B
Ibandronate
FDPS
12084.143
uM
16.05710
31.64790
-0.0190 -0.1938 0.4827 0.4042
0.9268
1.3499
HCC1395
TNBC
Basal B
Ibandronate
FDPS
12000.143
uM
7.09140
49.09560
-0.3307 -0.6774 0.4426 0.5216
0.9701
0.8939
HCC1395
TNBC
Basal B
ICRF-193
TOP2
TOP
12084.157
uM
inf
8.3170
0.6700 0.6698 4.1481 0.0506
0.8459
1.3475
HCC1395
TNBC
Basal B
ICRF-193
TOP2
TOP
12000.157
uM
5.80140
126.59960
0.0919 -1.0000 0.3564 0.2465
0.9180
0.7671
HCC1395
TNBC
Basal B
IKK16
IKK
NFKB
7436.093
uM
1.71150
3.09860
-0.9583 -1.0000 1.8507 0.4762
0.9952
1.2596
HCC1395
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7435.091
uM
10.95810
20.9510
-1.0000 -1.0000 1.6951 0.5709
0.9856
0.5716
HCC1395
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7436.091
uM
23.53280
29.92030
-0.9599 -0.9588 4.4587 0.4143
0.9978
1.2489
HCC1395
TNBC
Basal B
Ispinesib
KSP
Kinesin
7436.067
uM
0.03673
0.04246
-0.9711 -0.5301 4.9867 0.7857
0.9340
1.2834
HCC1395
TNBC
Basal B
Ispinesib
KSP
Kinesin
7435.067
uM
0.01113
0.01926
-0.9999 -0.7978 1.7403 1.0215
0.9797
0.7691
HCC1395
TNBC
Basal B
Ixabepilone
TUBB
TUBB
7436.095
uM
0.01696
0.02202
-0.9468 -0.2878 1.7422 0.7040
0.8234
1.3597
HCC1395
TNBC
Basal B
Ixabepilone
TUBB
TUBB
7435.095
uM
0.00671
0.00955
-0.8303 -0.4035 1.6795 0.8925
0.8773
0.8762
HCC1395
TNBC
Basal B
JNK-IN-5A
JNK
JNK
12084.144
uM
1.70250
1.60430
0.0230 0.1284 5.0000 0.3083
0.8559
1.4700
HCC1395
TNBC
Basal B
JNK-IN-5A
JNK
JNK
12000.168
uM
1.89760
2.22170
-0.6361 -0.6000 5.0000 0.6038
0.9752
0.7873
HCC1395
TNBC
Basal B
L-779450
BRAF
MAPK
12000.166
uM
26.11470
32.14790
-0.0409 -0.9135 5.0000 0.1196
0.9129
0.7468
HCC1395
TNBC
Basal B
L-779450
BRAF
MAPK
12084.161
uM
14.78670
26.51780
-0.5384 -1.0000 1.8809 0.1565
0.9896
1.4492
HCC1395
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7435.098
uM
inf
inf
0.8541 0.8541 0.0000 0.1309
0.1162
0.7702